1. Australia Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Nanollose Limited

Nanollose Limited

NC6.AX
Nanollose LimitedAU flagAustralian Securities Exchange
0.07
AUD
- -
- -
23.87MMarket Cap
Nanollose Limited
NC6.AX
(Australian Securities Exchange)

Recent

price

0.07

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
-0.02
-0.02
-0.02
-0.01
-0.01
-0.01
-0.01
-0.01
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.11
0.03
0.01
- -
0.02
- -
- -
-0.01
-0.02
Book Value per Share
0.12
0.04
0.01
0.01
0.02
0.01
- -
- -
- -
Tangible Book Value per Share
35
77
85
81
124
153
153
165
206
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
-4,053.23
-11,577.27
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-2
-2
-1
-1
-2
-1
-1
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
-3,531.81
-9,251.68
- -
Profit Margin (%)
4
3
1
1
3
1
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
4
3
1
1
3
2
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-52.83
-128.78
- -
- -
-108.25
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-54.9%
-277.21%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
7.76%
23.34%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.01
2024
- -
- -
- -
- -
-0.01
2025
- -
- -
- -
- -
-0.01

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Valneva SE (0OB3.L)
Veracyte, Inc. (VCYT)
Lipigon Pharmaceuticals AB (publ) (LPGO.ST)
Renovacor, Inc. (RCOR)
Biovica International AB (publ) (BIOVIC-B.ST)
MultiCell Technologies, Inc. (MCET)
Business
Nanollose Limited (ASX:NC6) is an Australia-based biomaterials company that researches, develops and commercializes microbial cellulose technologies to produce tree-free fibers, fabrics and novel materials with minimal environmental impact; its core products include Nullarbor tree-free lyocell and rayon fibers for textiles, Nufolium fibers for non-woven applications, MicroGel horticultural medium, and emerging animal-free, plastic-free leather-like materials derived from agricultural and industrial waste via a rapid fermentation process compatible with existing manufacturing equipment. Founded in 2014 and headquartered in Nedlands, Western Australia, the company targets sustainable textile, non-woven, horticultural and leather industries, primarily serving fashion brands, fabric manufacturers and eco-conscious consumers in Australia with emerging global partnerships. Recent developments include a July 2024 non-binding joint venture agreement with Paradise Textiles, the material science arm of India's Alpine Group, to jointly develop and commercialize Nullarbor-based yarns and fabrics through research, sample production and customer engagement; ongoing collaboration with Grasim Industries Ltd. of the Aditya Birla Group to scale microbial cellulose production; and the creation of the world's first wearable garment from Nullarbor tree-free rayon using liquid waste, validating its waste-to-clothing technology.